The value of FDG-PET in predicting therapeutic response to atezolizumab plus bevacizumab therapy for hepatocellular carcinoma

Authors

Institutions

Publication Details

Journal
Tenri Medical Bulletin
Published
2025-01-01
DOI
https://doi.org/10.12936/tenrikiyo.28-012
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The value of FDG-PET in predicting therapeutic response to atezolizumab plus bevacizumab therapy for hepatocellular carcinoma

Atsushi Takai, Masayuki Ueno, Shu Nagatomo
1 links
Tenri Medical Bulletin
Hepatocellular Carcinoma Treatment and Prognosis
article

The value of FDG-PET in predicting therapeutic response to atezolizumab plus bevacizumab therapy for hepatocellular carcinoma

Atsushi Takai, Masayuki Ueno, Shu Nagatomo
article en

Abstract

No abstract available for this paper.
Tenri Medical BulletinVol. 28(1)
Tenri Hospital (JP), Kyoto University Hospital (JP)
Good health and well-being
Openalex Percentile: Top 78%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The value of FDG-PET in predicting therapeutic response to atezolizumab plus bevacizumab therapy for hepatocellular carcinoma — Atsushi Takai, Masayuki Ueno, et al. · Tenri Medical Bulletin (2025) | TGRS Research Map | TGRS